Tomer Y, Greenberg D A, Barbesino G, Concepcion E, Davies T F
Division of Endocrinology and Metabolism, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
J Clin Endocrinol Metab. 2001 Apr;86(4):1687-93. doi: 10.1210/jcem.86.4.7372.
One of the hallmarks of the human autoimmune thyroid diseases (AITDs) is the production of high titers of autoantibodies against thyroglobulin and thyroid peroxidase that often precedes the development of clinical disease. A high percentage of family members of patients with AITDs have significant titers of thyroid antibodies (TAbs), suggesting a genetic predisposition for their development, and segregation analyses have favored a dominant mode of inheritance. The aim of the present study was to identify the susceptibility genes for TAb production. We completed a genome-wide scan in 56 multiplex families (323 individuals) in which all family members with AITDs and/or detectable TAbs were considered affected. The highest 2-point logarithm of odds (LOD) score of 3.6 was obtained for marker D2S325 on chromosome 2q33 at 210.9 centimorgans. This locus showed no evidence for linkage to Graves' disease or Hashimoto's thyroiditis (2-point LOD scores, 0.42 for Graves' disease and -0.60 for Hashimoto's thyroiditis), demonstrating that the gene in this region conferred susceptibility to TAbs, but that clinical disease development required additional genetic and/or environmental factors. We then fine-mapped the region linked with TAbs using 11 densely spaced microsatellite markers. Multipoint linkage analysis using these markers showed a maximum LOD score of 4.2 obtained for marker D2S155 at 209.8 centimorgans (with heterogeneity, alpha = 0.41). As the linked region contained the CTLA-4 and CD28 genes, we then tested whether they were the susceptibility genes for TAbs on chromosome 2q33. The CD28 gene was sequenced in 15 individuals, and a new C/T single nucleotide polymorphism (SNP) was identified in intron 3. Analysis of this SNP revealed no association with TAbs in the probands of the linked families (families that were linked with D2S155) compared with controls. The CTLA-4 gene was analyzed using the known A/G(49) SNP, and the results showed a significantly increased frequency of the G allele in the probands of the linked families compared with the probands of the unlinked families or with controls (P = 0.02). We concluded that 1) a major gene for thyroid autoantibody production was located on chromosome 2q33; 2) the TAb gene on chromosome 2q33 was most likely the CTLA-4 gene and not the CD28 gene; and 3) CTLA-4 contributed to the genetic susceptibility to TAb production, but there was no evidence that it contributed specifically to Graves' or Hashimoto's diseases.
人类自身免疫性甲状腺疾病(AITD)的一个标志是产生高滴度的抗甲状腺球蛋白和甲状腺过氧化物酶自身抗体,这通常先于临床疾病的发展。AITD患者的家庭成员中有很大比例具有显著滴度的甲状腺抗体(TAB),这表明其发病存在遗传易感性,而分离分析支持显性遗传模式。本研究的目的是确定产生TAB的易感基因。我们对56个多重家庭(323名个体)进行了全基因组扫描,其中所有患有AITD和/或可检测到TAB的家庭成员都被视为患病个体。在2号染色体2q33上的标记D2S325处,在210.9厘摩处获得了最高的两点对数优势(LOD)分数3.6。该位点没有显示出与格雷夫斯病或桥本甲状腺炎的连锁证据(两点LOD分数,格雷夫斯病为0.42,桥本甲状腺炎为 -0.60),这表明该区域的基因赋予了对TAB的易感性,但临床疾病的发展还需要其他遗传和/或环境因素。然后,我们使用11个紧密间隔的微卫星标记对与TAB相关的区域进行了精细定位。使用这些标记进行的多点连锁分析显示,在209.8厘摩处的标记D2S155获得了最高LOD分数4.2(异质性,α = 0.41)。由于连锁区域包含CTLA - 4和CD28基因,我们随后测试它们是否是2号染色体2q33上TAB的易感基因。对15名个体的CD28基因进行了测序,在内含子3中鉴定出一个新的C/T单核苷酸多态性(SNP)。与对照组相比,对该SNP的分析显示,在连锁家族(与D2S155连锁的家族)的先证者中,该SNP与TAB无关联。使用已知的A/G(49) SNP对CTLA - 4基因进行分析,结果显示,与未连锁家族的先证者或对照组相比,连锁家族的先证者中G等位基因的频率显著增加(P = 0.02)。我们得出以下结论:1)甲状腺自身抗体产生的一个主要基因位于2号染色体2q33上;2)2号染色体2q33上的TAB基因很可能是CTLA - 4基因而非CD28基因;3)CTLA - 4促成了对TAB产生的遗传易感性,但没有证据表明它对格雷夫斯病或桥本甲状腺炎有特异性贡献。